| LDR | 00918nam a2200289Ia 4500 | ||
| 001 | 100165313 | ||
| 003 | MiAaHDL | ||
| 005 | 20140428000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 120705s1915 inua 000 0 eng d | ||
| 035 | ⊔ | ⊔ | ‡asdr-osu.b29026234 |
| 035 | ⊔ | ⊔ | ‡a.b29026234 |
| 040 | ⊔ | ⊔ | ‡aOSU ‡cOSU ‡dUtOrBLW |
| 049 | ⊔ | ⊔ | ‡aOSUU |
| 090 | ⊔ | ⊔ | ‡aRM666.I7 ‡bL7 |
| 090 | ⊔ | ⊔ | ‡aRM666.I7 ‡bL7 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)798280565 |
| 245 | 0 | 0 | ‡aAlcresta Tablets of Ipecac in the treatment of pyorrhea alveolaris : ‡bwith some clinical reports. |
| 260 | ⊔ | ⊔ | ‡aIndianapolis : ‡bEli Lilly and Co., ‡cc1915. |
| 300 | ⊔ | ⊔ | ‡a21 p. ; ‡c18 cm. |
| 500 | ⊔ | ⊔ | ‡aCover title. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aIpecac (Drug) |
| 650 | ⊔ | 0 | ‡aPeriodontal disease ‡xTreatment. |
| 710 | 2 | ⊔ | ‡aEli Lilly and Company. |
| CID | ⊔ | ⊔ | ‡a100165313 |
| DAT | 0 | ⊔ | ‡a20120801103052.0 ‡b20140428000000.0 |
| DAT | 1 | ⊔ | ‡a20140429090604.0 ‡b2023-12-09T18:41:44Z |
| CAT | ⊔ | ⊔ | ‡aSDR-OSU ‡dIII - SIERRA ‡lloader.pl-003-015 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-osu.b29026234 ‡aosu ‡bSDR ‡cOSU ‡posu.32435007966187 ‡sOU ‡1.b29026234 |
| 974 | ⊔ | ⊔ | ‡bOU ‡cOSU ‡d20231209 ‡sgoogle ‡uosu.32435007966187 ‡y1915 ‡rpd ‡qbib ‡tUS bib date1 < 1929 |